Aspirin

阿司匹林

Report date: 2026/05/20 20:02:01
NME

Base Information

Drug NameAspirin
Drug Alias NameAcetylsalicylic acid乙酰水杨酸Bayaspirin阿斯匹灵阿司匹灵 +[21] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCyclooxygenases inhibitors
TargetsCyclooxygenases
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Esophageal adenocarcinomaSkin Melanoma +[128] 
Global Approved IndicationsSprains and StrainsHeadacheLow Back Pain +[21] 
Approved Indications in ChinaPainFever
Original Approved Country/TerritoryJapan
Original Approved Date1950/10/01
Country/TerritoryCzechiaBelgiumAngola +[43] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesInstitute Of Medical Sciences Of The Banaras Hindu University (Bhu),IndiaUtah State UniversityAmrita Institute Of Medical Sciences & Research Center +[64] 
Inactive CompaniesPlx PharmaIpsenFederal University Of Sao Paulo +[50] 
Active IndicationsCoronavirus Disease 2019 (COVID-19)Esophageal adenocarcinomaParturition +[70] 
Inactive IndicationsSkin MelanomaPsychotic DisordersDepressive Disorder, Treatment-Resistant +[58] 

Other Information

ATC CodeA01AD05B01AC06N02BA01
Related LinksWikipediaDrugBankKEGG